The blockbuster weight loss drug sold as Ozempic and Wegovy [has, on 21 March, gone] generic in countries that are home to 40 percent of the world’s population, significantly lowering the price of a costly medicine that had been largely unaffordable to nearly all but the wealthiest people. On Saturday, Novo Nordisk, the company that until now has had a monopoly on selling the drug, will lose patent protection in several of the world’s most populous countries. The first generic versions are expected to arrive in India as soon as this weekend. In the coming months, the generics are also expected to become available in China, Canada, Brazil, Turkey and South Africa.
There is nothing hostile about challenging your narrowmindedness with anecdote. You don’t need to care about every living being on this planet to understand that you can’t just pull a one size fits all blanket over a problem to make it go away.
There is nuance, individual expereince does matter when discussing public health issues. Your statement about people being too lazy to make the effort is clearly misjudged. The fact that i am one example of evidence of that does not mean i think its all about me. Seriously, you are out of touch.
It is funny that you address everyone here, talking about me, except for me. The person you are talking about.
Why don’t you have this conversation with me?